Todd Wallach

Todd Wallach has extensive work experience in various leadership roles in the biotechnology and medical industries. Todd is currently serving as the CEO of SOLUtion Medical and OncoSTING. In addition, they hold the position of Entrepreneur in Residence at Delaware Innovation Space and the University of Colorado Boulder. Previously, Todd served as the Chief Technology Officer at Moon Mark and held the role of President and CEO at Evogen, Inc. and Cognizance Biomarkers, LLC. Todd has also served as CEO and Chairman of Molecular Detection, Inc. and as the Chief Financial Officer at Aton Pharma, Inc. Todd's earlier experiences include being the Vice President of Finance & Operations at Acuity Pharmaceuticals. Furthermore, they are a member of The Explorers Club.

Todd Wallach has a diverse education history. Todd obtained a Bachelor of Science degree in Mechanical Engineering from Purdue University in 1986. Following this, they pursued an MBA in Management and Finance at Rider University from 1986 to 1991. In 1998, Todd attended the University of Pennsylvania's Wharton School of Business and School of Engineering and Applied Science, where they earned a Master of Science in Management of Technology. In 2002, they returned to the University of Pennsylvania to pursue a Masters degree in Biotechnology.